Cardio Diagnostics (NASDAQ:CDIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Cardio Diagnostics (NASDAQ:CDIO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)
Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD’s Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions
Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community